Response to Hasan et aḷ., “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: A retrospective cohort study”
Journal
Journal of the American Academy of Dermatology
Series/Report No.
Journal of the American Academy of Dermatology
ISSN
0190-9622
Date Issued
2024-01-01
Author(s)
DOI
10.1016/j.jaad.2024.06.105
Subjects
FOXP3
atopic dermatitis
cutaneous T-cell lymphoma
dupilumab
severity
Publisher
Elsevier BV
Type
letter